COVID-19 Vaccines – Pfizer Vaccine Use in Children
September 20, 2021 - Pfizer announced top-line results from a Phase 2/3 trial evaluating the Comirnaty® vaccine in children ages 5 to 11 years old. This is the first COVID-19 vaccine data available in children younger than 12 years.
Download PDF
